ArticleJournal of evaluation in clinical practice2020

Comparison of effectiveness and drug cost between dipeptidyl peptidase-4 inhibitor and biguanide as the first-line anti-hyperglycaemic medication among Japanese working generation with type 2 diabetes.

Noriko Ihana-Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.